2.5000
24-فبراير-25 16:45:00
15 متأخرة بدقائق
الأسهم
-0.0500
-1.96%
نطاق اليوم
2.4900 - 2.6200
ISIN
N/A
المصدر
NASDAQ
Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease
08 فبراير 2021 08:30:00 بحسب Nasdaq GlobeNewswire
Cassava Sciences’ Simufilam Improves Cognition and Behavior in Alzheimer’s Disease in Interim Analysis of Open-label Study
02 فبراير 2021 08:30:00 بحسب Nasdaq GlobeNewswire
Cassava Sciences Appoints Dr. James Kupiec as Chief Clinical Development Officer
04 يناير 2021 08:30:00 بحسب Nasdaq GlobeNewswire